Cognyte Software Ltd. (NASDAQ:CGNT – Get Free Report) shares passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $4.39 and traded as high as $5.19. Cognyte Software shares last traded at $5.11, with a volume of 220,193 shares traded.
Analysts Set New Price Targets
Several research analysts have commented on the stock. StockNews.com upgraded shares of Cognyte Software from a “sell” rating to a “hold” rating in a report on Wednesday, June 21st. Evercore ISI increased their price target on shares of Cognyte Software from $3.00 to $5.00 in a research report on Friday, June 16th.
Read Our Latest Stock Analysis on CGNT
Cognyte Software Stock Up 0.4 %
Cognyte Software (NASDAQ:CGNT – Get Free Report) last issued its quarterly earnings data on Thursday, June 15th. The medical device company reported ($0.23) earnings per share for the quarter, missing the consensus estimate of ($0.22) by ($0.01). The business had revenue of $73.40 million for the quarter, compared to the consensus estimate of $71.53 million. Cognyte Software had a negative net margin of 30.95% and a negative return on equity of 42.06%. Cognyte Software’s revenue was down 15.0% compared to the same quarter last year. During the same period in the previous year, the business posted ($0.85) EPS. On average, analysts anticipate that Cognyte Software Ltd. will post -0.7 EPS for the current fiscal year.
Hedge Funds Weigh In On Cognyte Software
A number of institutional investors have recently modified their holdings of CGNT. Vanguard Personalized Indexing Management LLC bought a new position in shares of Cognyte Software in the first quarter valued at approximately $34,000. Quantbot Technologies LP bought a new position in shares of Cognyte Software in the first quarter valued at approximately $45,000. M&T Bank Corp raised its position in shares of Cognyte Software by 52.8% in the first quarter. M&T Bank Corp now owns 16,559 shares of the medical device company’s stock valued at $56,000 after purchasing an additional 5,724 shares during the period. Allspring Global Investments Holdings LLC bought a new position in shares of Cognyte Software in the fourth quarter valued at approximately $61,000. Finally, Alpine Global Management LLC bought a new position in shares of Cognyte Software in the fourth quarter valued at approximately $62,000. Institutional investors own 60.24% of the company’s stock.
About Cognyte Software
Cognyte Software Ltd. provides an investigative analytics software to governments and enterprises worldwide. Its Actionable Intelligence for a Safer World, an open software designed to help governments and enterprises accelerate and enhance the effectiveness of investigations. The company also offers network intelligence analytics, open source and threat intelligence analytics, and operational intelligence analytics solutions.
Featured Stories
- Five stocks we like better than Cognyte Software
- What is the price-to-earnings growth (PEG) ratio?
- 5 Best Fintech Stocks to Buy Now
- What is the Australian Securities Exchange (ASX)
- UPS Slipping To More Attractive Levels On Weak OutlookÂ
- ESG Stocks, What Investors Should Know
- More Good News Coming? GoodRx Spikes Ahead of Q2 Earnings
Receive News & Ratings for Cognyte Software Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognyte Software and related companies with MarketBeat.com's FREE daily email newsletter.
